Substance use continues to contribute to significant morbidity and mortality in the United
States, for both women and men, more so than any other preventable health condition. To …

Compounds known to be successful in the treatment of alcohol use disorder include the
aversive agent, Disulfiram, the glutamatergic NMDA receptor antagonist, Acamprosate, and …

Alcohol use disorder (AUD) is a significant contributor to morbidity and mortality in the
United States. It contributes to over 140,000 annual deaths, to over 200 related diseases …

Alcohol use disorder (AUD) is highly prevalent and among the leading causes of morbidity
and mortality in the United States. Pharmacotherapies for AUD are limited, thus making …

Compared to other medical disorders, including other brain diseases, the number of
medications approved for alcohol use disorder (AUD) is very small. Disulfiram, naltrexone …

SLC6A4, the gene encoding the serotonin transporter protein (5-HTT), has been extensively
examined as a risk factor for alcohol dependence (AD). More recently, variability in the …

Introduction: Alcohol use disorder (AUD) is highly prevalent; costly economically, socially,
and interpersonally; and grossly undertreated. The low rate of utilization of medications with …

Genetics account for moderate variation of individual differences in developing alcohol use
disorder (AUD), but it is unclear which genetic variations contribute to AUD risk. One …

For more than 25 years, researchers have made advances in developing medications to
treat alcohol use disorder (AUD), highlighted by the US Food and Drug Administration's …

The personality characteristics of children of exposed to parental problem drinking have
been of interest to clinicians and researchers for several decades, but personality research …